
Regeneron Pharmaceuticals Inc
Rilonacept Injection, Dupilumab Injection, Aflibercept Injection, Sarilumab Injection, Emiplimab-Rwlc Injection, Alirocumab Injection
Incorporated in 1988, Regeneron Pharmaceuticals Inc belongs to the Biotechnology industry and specialises in Rilonacept Injection, Dupilumab Injection, Aflibercept Injection, Sarilumab Injection, Emiplimab-Rwlc Injection, Alirocumab Injection. The company is located in Tarrytown, United States and has an estimated revenue and employee in the range of $1,000 to $10,000 million and 5001-10000 respectively.
We have 7663 contacts in our database, out of which 12% are decision makers. The distribution of leads are as follows:
In January, 2020 regeneron.com's total website visitor was 183166, increased by 30% from previous month. Some key metrics are Average time spent on site is 1 minutes, Bounce Rate is 69% and average page per visit is 1 respectively.
We Verified regeneron.com server for email deliverability.
Harvest Health & Recreation has acquired Franklin Labs, LLC, a subsidiary of CannaPharmacy, f...
Microsoft today declared that it has acquired Affirmed Networks, an organization that specializes...
Perficient acquires Catalyst Networks, a Georgia corporation doing business as Brainjocks, which ...
Cognizant enters into an agreement to acquire the U.S.-based digital marketing consultancy Lev fo...